Page last updated: 2024-08-24

trofosfamide and Recrudescence

trofosfamide has been researched along with Recrudescence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bufalo, NE; Leite, JL; Romaldini, JH; Santos, RB; Ward, LS1
Elmlinger, MW; Plikat, K; Reichle, A; Schölmerich, J1
Andersson, PO; Braide, I; Nilsson-Ehle, H1

Other Studies

3 other study(ies) available for trofosfamide and Recrudescence

ArticleYear
Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease.
    European journal of endocrinology, 2010, Volume: 162, Issue:2

    Topics: Adult; Autoimmunity; Case-Control Studies; Cyclophosphamide; Cytochrome P-450 CYP1A1; Female; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Graves Disease; Herpesvirus 7, Human; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Regression, Psychology; Risk Factors; Roseolovirus Infections; Tumor Suppressor Protein p53; Young Adult

2010
[Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
    Deutsche medizinische Wochenschrift (1946), 2003, Feb-07, Volume: 128, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cyclophosphamide; Female; Hemangiopericytoma; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lactones; Liver Neoplasms; Pioglitazone; Prednisolone; Recurrence; Sulfones; Thiazoles; Thiazolidinediones; Time Factors

2003
Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:12

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Palliative Care; Recurrence; Remission Induction; Salvage Therapy

2002